左主干狭窄患者经皮冠状动脉介入与冠状动脉旁路移植术的系统评价与荟萃分析
该系统评价与荟萃分析纳入4项随机临床试验共4394例左主干狭窄患者,比较药物洗脱支架PCI与CABG的长期安全性。两组全因死亡、心肌梗死或卒中的复合终点风险相当(HR 1.06,95%CI 0.90-1.24),但PCI组重复血运重建风险更高(HR 1.70,95%CI 1.42-2.05)。在低至中等复杂度的冠心病患者中,PCI与CABG安全性相当。
要点
- 左主干狭窄患者PCI与CABG的全因死亡、心梗或卒中复合终点风险相当。
- PCI组重复血运重建风险显著高于CABG组(HR 1.70)。
- 低至中等SYNTAX评分及不同代药物洗脱支架的敏感性分析结果一致。
核心结论
- 在左主干狭窄且冠状动脉病变低至中等复杂度的患者中,PCI与CABG的安全性相当。
- PCI后重复血运重建较CABG更常见。
研究设计与样本
- 系统评价与荟萃分析,纳入4项随机临床试验,共4394例左主干狭窄患者。
- 纳入标准为随机临床试验、左主干狭窄患者、PCI对比CABG、仅使用药物洗脱支架、临床随访至少3年。
- 采用固定效应和随机效应模型合并试验水平风险比(HR)及95%CI。
主要发现
- PCI与CABG的全因死亡、心肌梗死或卒中复合终点风险相当:固定效应模型HR 1.06(95%CI 0.90-1.24,P=.48),随机效应模型HR 1.06(95%CI 0.85-1.32,P=.60)。
- 低至中等SYNTAX评分亚组随机效应模型HR 1.02(95%CI 0.74-1.41,P=.89)。
- 第一代药物洗脱支架HR 0.90(95%CI 0.68-1.20,P=.49),第二代HR 1.19(95%CI 0.82-1.73,P=.36)。
- PCI组重复血运重建风险增加:HR 1.70(95%CI 1.42-2.05,P<.001)。
- 5年全因死亡、心肌梗死或卒中发生率:PCI组18.3%(319例事件),CABG组16.9%(292例事件)。
关键数值与推荐
- 主要终点为长期随访全因死亡、心肌梗死或卒中的复合终点。
- 次要终点包括重复血运重建及全因死亡、心肌梗死、卒中或重复血运重建的复合终点。
- 根据GRADE评价,主要复合终点的证据质量高。
临床怎么用
- 对于左主干狭窄且冠状动脉病变低至中等复杂度的患者,PCI可作为CABG的替代选择。
- 选择PCI时应告知患者重复血运重建风险较高。
局限性
- 纳入试验数量较少(4项)。
- 左主干狭窄试验的合并估计与无左主干狭窄的多支血管病变试验总体存在显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In patients with left main coronary artery (LMCA) stenosis, coronary artery bypass grafting (CABG) has been the standard therapy for several decades. However, some studies suggest that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative. OBJECTIVE: To compare the long-term safety of PCI with drug-eluting stent vs CABG in patients with LMCA stenosis. DATA SOURCES: PubMed, Scopus, EMBASE, Web of Knowledge, and ScienceDirect databases were searched from December 18, 2001, to February 1, 2017. Inclusion criteria were randomized clinical trial, patients with LMCA stenosis, PCI vs CABG, exclusive use of drug-eluting stents, and clinical follow-up of 3 or more years. DATA EXTRACTION AND SYNTHESIS: Trial-level hazard ratios (HRs) and 95% CIs were pooled by fixed-effect and random-effects models with inverse variance weighting. Time-to-event individual patient data for the primary end point were reconstructed. Sensitivity analyses according to drug-eluting stent generation and coronary artery disease complexity were performed. MAIN OUTCOMES AND MEASURES: The primary end point was a composite of all-cause death, myocardial infarction, or stroke at long-term follow-up. Secondary end points included repeat revascularization and a composite of all-cause death, myocardial infarction, stroke, or repeat revascularization at long-term follow-up. RESULTS: A total of 4 randomized clinical trials were pooled; 4394 patients were included in the analysis. Of these, 3371 (76.7%) were men; pooled mean age was 65.4 years. According to Grading of Recommendations, Assessment, Development and Evaluation, evidence quality with respect to the primary composite end point was high. Percutaneous coronary intervention and CABG were associated with a comparable risk of all-cause death, myocardial infarction, or stroke both by fixed-effect (HR, 1.06; 95% CI, 0.90-1.24; P = .48) and random-effects (HR, 1.06; 95% CI, 0.85-1.32; P = .60) analysis. Sensitivity analyses according to low to intermediate Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score (random-effects: HR, 1.02; 95% CI, 0.74-1.41; P = .89) and drug-eluting stent generation (first generation: HR, 0.90; 95% CI, 0.68-1.20; P = .49; second generation: HR, 1.19; 95% CI, 0.82-1.73; P = .36) were consistent. Kaplan-Meier curve reconstruction did not show significant variations over time between the techniques, with a 5-year incidence of all-cause death, myocardial infarction, or stroke of 18.3% (319 events) in patients treated with PCI and 16.9% (292 events) in patients treated with CABG. However, repeat revascularization after PCI was increased (HR, 1.70; 95% CI, 1.42-2.05; P < .001). Other individual secondary end points did not differ significantly between groups. Finally, pooled estimates of trials with LMCA stenosis tended overall to differ significantly from those of trials with multivessel coronary artery disease without left main LMCA stenosis. CONCLUSIONS AND RELEVANCE: Percutaneous coronary intervention and CABG show comparable safety in patients with LMCA stenosis and low to intermediate-complexity coronary artery disease. However, repeat revascularization is more common after PCI.
引用
- Giacoppo D, Colleran R, Cassese S, et al. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis. JAMA Cardiol. 2017. PMID: 28903139. doi:10.1001/jamacardio.2017.2895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。